Daniel Grosslight
Stock Analyst at Citigroup
(1.24)
# 3,710
Out of 5,182 analysts
134
Total ratings
34.94%
Success rate
-13.01%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Initiates: Buy | $145 | $113.83 | +27.38% | 1 | Apr 15, 2026 | |
| PAHC Phibro Animal Health | Initiates: Neutral | $62 | $52.50 | +18.10% | 1 | Apr 15, 2026 | |
| IDXX IDEXX Laboratories | Initiates: Neutral | $650 | $553.66 | +17.40% | 1 | Apr 15, 2026 | |
| HSIC Henry Schein | Initiates: Buy | $100 | $73.80 | +35.50% | 1 | Apr 15, 2026 | |
| NVST Envista Holdings | Initiates: Neutral | $29 | $25.90 | +11.97% | 1 | Apr 15, 2026 | |
| ELAN Elanco Animal Health | Initiates: Buy | $30 | $21.80 | +37.61% | 1 | Apr 15, 2026 | |
| XRAY DENTSPLY SIRONA | Initiates: Sell | $10 | $11.48 | -12.89% | 1 | Apr 15, 2026 | |
| ALGN Align Technology | Initiates: Buy | $240 | $178.40 | +34.53% | 1 | Apr 15, 2026 | |
| PHR Phreesia | Downgrades: Neutral | $25 → $10 | $9.37 | +6.72% | 9 | Mar 31, 2026 | |
| HCAT Health Catalyst | Maintains: Neutral | $2.75 → $1.75 | $1.27 | +37.80% | 13 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $13 → $24 | $26.33 | -8.85% | 14 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $6 | $5.95 | +0.84% | 14 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $32 | $24.69 | +29.61% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.5 → $3.5 | $2.29 | +52.84% | 9 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $27.89 | -32.77% | 7 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $3.79 | +5.54% | 7 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $21 | $23.06 | -8.93% | 5 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $35 | $25.27 | +38.50% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $4 | $3.49 | +14.61% | 1 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $190 → $244 | $202.82 | +20.30% | 11 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $820 → $860 | $822.63 | +4.54% | 8 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $1.97 | +407.61% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $10.00 | -20.00% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $0.92 | +35.35% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $5.19 | -32.56% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $13.08 | -0.61% | 1 | Dec 11, 2019 |
Zoetis
Apr 15, 2026
Initiates: Buy
Price Target: $145
Current: $113.83
Upside: +27.38%
Phibro Animal Health
Apr 15, 2026
Initiates: Neutral
Price Target: $62
Current: $52.50
Upside: +18.10%
IDEXX Laboratories
Apr 15, 2026
Initiates: Neutral
Price Target: $650
Current: $553.66
Upside: +17.40%
Henry Schein
Apr 15, 2026
Initiates: Buy
Price Target: $100
Current: $73.80
Upside: +35.50%
Envista Holdings
Apr 15, 2026
Initiates: Neutral
Price Target: $29
Current: $25.90
Upside: +11.97%
Elanco Animal Health
Apr 15, 2026
Initiates: Buy
Price Target: $30
Current: $21.80
Upside: +37.61%
DENTSPLY SIRONA
Apr 15, 2026
Initiates: Sell
Price Target: $10
Current: $11.48
Upside: -12.89%
Align Technology
Apr 15, 2026
Initiates: Buy
Price Target: $240
Current: $178.40
Upside: +34.53%
Phreesia
Mar 31, 2026
Downgrades: Neutral
Price Target: $25 → $10
Current: $9.37
Upside: +6.72%
Health Catalyst
Mar 13, 2026
Maintains: Neutral
Price Target: $2.75 → $1.75
Current: $1.27
Upside: +37.80%
Mar 10, 2026
Upgrades: Neutral
Price Target: $13 → $24
Current: $26.33
Upside: -8.85%
Mar 3, 2026
Maintains: Neutral
Price Target: $9 → $6
Current: $5.95
Upside: +0.84%
Mar 3, 2026
Maintains: Buy
Price Target: $34 → $32
Current: $24.69
Upside: +29.61%
Mar 3, 2026
Maintains: Buy
Price Target: $4.5 → $3.5
Current: $2.29
Upside: +52.84%
Mar 3, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $27.89
Upside: -32.77%
Feb 26, 2026
Maintains: Buy
Price Target: $6 → $4
Current: $3.79
Upside: +5.54%
Feb 25, 2026
Maintains: Buy
Price Target: $63 → $21
Current: $23.06
Upside: -8.93%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $35
Current: $25.27
Upside: +38.50%
Jan 9, 2026
Maintains: Buy
Price Target: $7 → $4
Current: $3.49
Upside: +14.61%
Jan 9, 2026
Upgrades: Buy
Price Target: $190 → $244
Current: $202.82
Upside: +20.30%
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $822.63
Upside: +4.54%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $1.97
Upside: +407.61%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $10.00
Upside: -20.00%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $0.92
Upside: +35.35%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $5.19
Upside: -32.56%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $13.08
Upside: -0.61%